Drug Prices

The Berkeley Research Group recently published an updated report that compared sales across federal prescription drug programs, to…

The Brookings Institution recently published a study on the outcomes under the No Surprises Act arbitration process, finding that…

Colorado’s General Assembly passed a law in 2019 that allowed the Colorado Department of Health Care Policy and Financing (HCPF)…

Recently, the Institute for Clinical and Economic Review (ICER) published its annual Unsupported Price Increase Report,…

Generic drug shortages have been in the news for several months now, with many stakeholders and interested parties trying to find…

The Biden Administration recently published a draft proposal to exercise “march-in” rights regarding generic options for patented…

Welcome to the latest edition of Policy and Medicine Compliance Update. In this month's coverage, we delve into the intricate…

A new report from AARP found that the 25 drugs that accounted for the highest Medicare Part D spending in 2021 more than tripled…

On August 21, 2023, the Centers for Medicare & Medicaid Services (CMS) released draft guidance on a new program that will…

Medicare will negotiate the prices of top-selling drugs for blood clots, diabetes, cancer and arthritis, flexing newly granted…